| Name | Title | Contact Details |
|---|
Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps is a non-profit integrated health care delivery system based in San Diego, Calif. We treat more than 700,000 patients annually through the dedication of 3,000 affiliated physicians and more than 15,000 employees among our five acute-care hospital campuses, hospice and home health care services, 27 outpatient centers and clinics, and hundreds of affiliated physician offices throughout the region. Medical Excellence Every Step of the Way Recognized as a leader in disease and injury prevention, diagnosis and treatment, Scripps has been ranked four times as one of the nation`s best health care systems by Truven Health Analytics. Our hospitals are consistently ranked by U.S. News & World Report among the nation`s best – and Scripps is regularly recognized by Fortune, Working Mother magazine and The Advisory Board as one of the best places in the nation to work. Scripps is also at the forefront of clinical research, genomic medicine and wireless health care. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges.
Relmada Therapeutics (OTCQB: RLMD) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. Relmada has a diversified portfolio of four lead products at various stages of development including d-Methadone (REL-1017) its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine (REL-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (REL-1028) its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. Relmada`s product development efforts are guided by the internationally recognized scientific expertise of our research team. Relmada`s approach is expected to reduce clinical development risks and costs while potentially delivering valuable products in areas of high unmet medical needs.
Oakwood Place Assisted Living is a Davenport, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
IPS Research Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oklahoma City, OK. To find more information about IPS Research Company, please visit www.ipsresearch.com